@article {Rothmanbcr0520114280, author = {Richard D Rothman and Rory B Weiner and Harrison Pope and Gen Kanayama and Adolph M Hutter, Jr. and Michael A Fifer and G William Dec, Jr. and Aaron L Baggish}, title = {Anabolic androgenic steroid induced myocardial toxicity: an evolving problem in an ageing population}, volume = {2011}, elocation-id = {bcr0520114280}, year = {2011}, doi = {10.1136/bcr.05.2011.4280}, publisher = {BMJ Publishing Group}, abstract = {Widespread use of anabolic androgenic steroid (AAS) abuse is a rapidly increasing public health concern with an expanding demographic. Previous studies and reports have been exclusive to young individuals at low risk for traditional, non-AAS associated, cardiovascular disease. To date, the impact of AAS use on older patients has not been well characterised. The patient herein presented documents a dramatic case of an older individual who developed decompensated heart failure secondary to illicit use of AAS, highlighting an evolving problem among a rapidly expanding demographic and illustrating that a) AAS, used to alter appearance or augment performance, is no longer an issue confined to young adults; b) older individuals with ageing myocardium may be particularly susceptible to AAS toxicity and may present with fulminate congestive heart failure; and that c) AAS abstinence coupled with traditional heart failure pharmacotherapy may be an effective treatment for this condition.}, URL = {https://casereports.bmj.com/content/2011/bcr.05.2011.4280}, eprint = {https://casereports.bmj.com/content/2011/bcr.05.2011.4280.full.pdf}, journal = {Case Reports} }